Paris
France
25
2019-12-05
The entities that hold a legal rights for patent applications filed by inventor Sansonetti Philippe:
Philippe Sansonetti from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:
Method of culturing segmented filamentous bacteria in vitro
#2 | 2019-01-17METHOD AND DEVICE FOR CONSERVING VIABLE AND FUNCTIONAL HUMAN POLYMORPHONUCLEAR NEUTROPHILS
#3 | 2017-10-19NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS
#4 | 2017-02-23METHOD AND DEVICE FOR CONSERVING VIABLE AND FUNCTIONAL HUMAN POLYMORPHONUCLEAR NEUTROPHILS
#5 | 2016-11-03Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof
#6 | 2016-02-18METHODS TO OBTAIN A NOVEL CLASS OF GRAM NEGATIVE BACTERIA ANTIBIOTICS WHICH TARGET AN UNKNOWN CELL DIVISION ASSOCIATED PROTEIN LOP1
#7 | 2015-12-03NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS
#8 | 2015-10-15Glycoconjugates and their use as potential vaccines against infection by
#9 | 2015-02-19Glycoconjugates and use thereof as vaccine against serotype 3a and X
#10 | 2014-11-13Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof
#11 | 2014-06-12Glycoconjugates and their use as potential vaccines against infection by
#12 | 2013-09-19GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI
#13 | 2011-01-27Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolution
#14 | 2010-12-23Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#15 | 2010-09-23Glycoconjugates and use thereof as vaccine against serotype 3a and X
#16 | 2010-08-05SHIGELLA IPAD PROTEIN AND ITS USE AS A VACCINE AGAINST SHIGELLA INFECTION
#17 | 2009-12-31Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#18 | 2009-01-15Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#19 | 2008-05-15Glycoconjugates and their use as potential vaccines against infection by
#20 | 2007-04-05Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#21 | 2006-11-16Transformed
#22 | 2006-09-28Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#23 | 2006-07-18Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#24 | 2005-12-29CARD-4 molecules and uses thereof
#25 | 2005-02-10Transformed
443605 ⎘